Composition
| Component | Per vial | Research focus |
|---|---|---|
| GHK-Cu | 50 mg | Collagen formation, wound models |
| BPC-157 | 10 mg | Blood vessel formation |
| TB-500 | 10 mg | Cell migration |
| KPV | 10 mg | NF-κB, inflammatory cytokines |
The difference from GLOW
KPV corresponds to amino acids 11–13 of α-MSH and dampens inflammatory pathways in studies without affecting pigmentation, adding an inflammation-related angle to the three regeneration peptides of the GLOW blend. No studies of the four-way combination exist.
Status
No component is approved; BPC-157 and TB-500 are on the anti-doping prohibited list. Research use only.
Background in the magazine: GLOW and KLOW: what is in the blends








